GLASGOW—Periurethral injections of polyacrylamid hydrogel (PAHG), a new bulking agent, are a safe and effective option as a salvage therapy for women with severe stress urinary incontinence (SUI) ...

Gastro-oesophageal reflux disease (GORD) is a common condition that can have a significant impact on the quality of life of an individual. It is caused by failure of the sphincter mechanism at the ...

Jan. 13, 2006 -- The US Food and Drug Administration (FDA) approved in 2005 an injectable bulking agent for the treatment of stress urinary incontinence in women with intrinsic sphincteric deficiency; ...

Injecting a bulking agent into the anal canal improves symptoms of faecal incontinence when compared to a sham placebo, according to the first controlled trial to show that this treatment is effective ...

SOLESTA injectable gel by Oceana Therapeutics The FDA has approved Solesta gel (Oceana Therapeutics), a biocompatible tissue bulking agent consisting of dextranomer microspheres and stabilized sodium ...

Most patients with faecal incontinence are managed with conservative measures and biofeedback techniques Sacral nerve stimulation has dramatically changed the management of patients with faecal ...

Postprostatectomy incontinence (PPI) refractory to conservative treatment can be managed with a urethral bulking agent or an artificial urinary sphincter (AUS). There are few prospective data ...

Current evidence on the safety and efficacy of endoscopic injection of bulking agents for gastro-oesophageal reflux disease does not appear adequate for this procedure to be used without special ...